Study of Humoral Immunity against Two Antigenic Lines of Influenza B Virus in Different Age Groups
Journal of microbiology, epidemiology and immunobiology · 15.11.2026 · 103 (5) · 680-693
DOI: 10.36233/0372-9311-770 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of microbiology, epidemiology and immunobiology, online erschienen am 15.11.2026. Verfasst von P. A. Kudar und 10 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Antibodies to hemagglutinin (HA) and neuraminidase (NA) help neutralize the virus, but the high variability of HA limits their effectiveness. Meanwhile, antibodies to NA reduce replication and provide cross-immunity, making NA a promising target antigen for vaccine development. The aim of the research was conducting a phylogenetic analysis of influenza B viruses and assessing the specificity of antibodies to HA and NA of the B/Yamagata and B/Victoria viruses in the blood of patients depending on their age. Materials and methods. A phylogenetic analysis of the sequences encoding HA and NA of influenza B/Victoria and B/Yamagata viruses was carried out, and the specificity of antibodies in 145 blood plasma samples from patients of different ages examined in 2023 was assessed in relation to HA and NA of these lineages.
Results
Phylogenetic analysis revealed heterogeneity in the NA of B/Victoria lineage viruses, including viruses with an NA structure similar to the B/Yamagata lineage. Among patients aged 18–59 years examined in 2023, higher titers of antibodies to HA and NA of the B/Yamagata lineage were detected compared to B/Victoria. Protective titers of antibodies to HA were absent in the majority of patients of all age groups, while seropositive titers of antibodies to NA were detected in 39–65% of those examined.
Conclusion
The higher frequency of detection of antibodies to NA compared to antibodies to HA may indicate a longer duration of NA-specific immunity. NA of influenza B viruses is a promising target for the development of vaccines with a broad spectrum of protection.
Zitieren
APA
Kudar, P. A., Desheva, Y. A., Wong, P. F., Krylova, E. A., Guzenkov, D. S., Sokolovskiy, D. D., Shvedova, T. N., Kopylova, N. V., Kurpyaeva, M. O., Dyakov, I. N., & Rudenko, L. G. (2026). Study of Humoral Immunity against Two Antigenic Lines of Influenza B Virus in Different Age Groups. Journal of microbiology, epidemiology and immunobiology, 103(5), 680-693. https://doi.org/10.36233/0372-9311-770
Vancouver
Kudar PA, Desheva YA, Wong PF, Krylova EA, Guzenkov DS, Sokolovskiy DD, et al. Study of Humoral Immunity against Two Antigenic Lines of Influenza B Virus in Different Age Groups. Journal of microbiology, epidemiology and immunobiology. 2026;103(5):680-693. doi:10.36233/0372-9311-770
BibTeX
@article{Kudar2026,
author = {Kudar, P. A. and Desheva, Yu. A. and Wong, P. F. and Krylova, E. A. and Guzenkov, D. S. and Sokolovskiy, D. D. and Shvedova, T. N. and Kopylova, N. V. and Kurpyaeva, M. O. and Dyakov, I. N. and Rudenko, L. G.},
title = {Study of Humoral Immunity against Two Antigenic Lines of Influenza B Virus in Different Age Groups},
journal = {Journal of microbiology, epidemiology and immunobiology},
year = {2026},
volume = {103},
number = {5},
pages = {680--693},
doi = {10.36233/0372-9311-770}
}
EUVIMED